( S ( NP-SBJ ( NNS Analysts ) ) ( VP ( VBD said ) ( SBAR ( S ( NP-SBJ-1 ( NP ( NN profit ) ) ( PP ( IN for ) ( NP ( NP ( DT the ) ( QP ( NN dozen ) ( CC or ) ( RB so ) ) ( JJ big ) ( NN drug ) ( NNS makers ) ) ( PP ( IN as ) ( NP ( DT a ) ( NN group ) ) ) ) ) ) ( VP ( VBZ is ) ( VP ( VBN estimated ) ( S ( VP ( TO to ) ( VP ( VB have ) ( VP ( VBN climbed ) ( NP-EXT ( QP ( IN between ) ( CD 11 ) ( NN % ) ( CC and ) ( CD 14 ) ( NN % ) ) ) ) ) ) ) ) ) ) ) ) )